Page last updated: 2024-08-21

azomycin and Retinopathy of Prematurity

azomycin has been researched along with Retinopathy of Prematurity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Shabrawey, M; Bartoli, M; Behzadian, MA; Caldwell, RB; Caldwell, RW; El-Remessy, AB; Istanboli, M; Labazi, M; Marcus, DM1

Other Studies

1 other study(ies) available for azomycin and Retinopathy of Prematurity

ArticleYear
HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.
    Investigative ophthalmology & visual science, 2009, Volume: 50, Issue:10

    Topics: Animals; Blotting, Western; Capillaries; Disease Models, Animal; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Indoles; Infant, Newborn; Intercellular Adhesion Molecule-1; Lipid Peroxidation; Mice; Nitroimidazoles; Oxygen; Phosphorylation; Retinal Neovascularization; Retinal Vessels; Retinopathy of Prematurity; STAT3 Transcription Factor; Superoxides; Vascular Endothelial Growth Factor A

2009